Literature DB >> 4163795

Vaccinia Gangrenosa with normal humoral antibodies. A case possibly due to deficient cellular immunity treated with N-methylisatin beta-thiosemicarbazone (Compound 33T57, Marboran).

O Hansson, S G Johansson, B Vahlquist.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4163795     DOI: 10.1111/j.1651-2227.1966.tb17653.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


× No keyword cloud information.
  11 in total

1.  Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans.

Authors:  Masanori Terajima; Laura Orphin; Anita M Leporati; Pamela Pazoles; John Cruz; Alan L Rothman; Francis A Ennis
Journal:  Hum Immunol       Date:  2008-10-26       Impact factor: 2.850

2.  Fatal varicella generalisata in a child with immunopathy and hereditary neurological syndrome. A report with autopsy, electron microscopy and virus isolation.

Authors:  R Berg; O Hansson; F Nordbring; P Sourander; U Stenram; R Willén
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1969

3.  Treatment with methisazone of complications following smallpox vaccination.

Authors:  B Jaroszyńska-Weinberger
Journal:  Arch Dis Child       Date:  1970-08       Impact factor: 3.791

4.  Problems of smallpox immunization.

Authors:  A L Libov
Journal:  Indian J Pediatr       Date:  1967-12       Impact factor: 1.967

5.  Lung involvement in progressive vaccinia.

Authors:  D S Chudwin; M J Cowan; D W Wara; A C Johnson
Journal:  West J Med       Date:  1981-05

6.  Occupationally-acquired smallpox in an IgM-deficient health worker.

Authors:  L B Brilliant; J H Nakano; T Kitamura; L N Hodakevic; P B Bharucha
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

7.  Vaccinia gangrenosa and 1-methylisatin 3-thiosemicarbazone (methisazone).

Authors:  C E Van Rooyen; J Casey; S H Lee; R Faulkner; H P Dincsoy
Journal:  Can Med Assoc J       Date:  1967-07-22       Impact factor: 8.262

Review 8.  Poxvirus pathogenesis.

Authors:  R M Buller; G J Palumbo
Journal:  Microbiol Rev       Date:  1991-03

9.  Progressive vaccinia: immunological aspects and transfer factor therapy.

Authors:  L Timár; J Budai; G Nyerges; R Szigeti; I Hollós; I Sonkoly
Journal:  Infection       Date:  1978       Impact factor: 3.553

10.  Cellular immunity in vaccinia infection of mice. Anti-thymocyte serum effects on primary and secondary responsiveness.

Authors:  M S Hirsch; A J Nahmias; F A Murphy; J H Kramer
Journal:  J Exp Med       Date:  1968-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.